OMass Revenue and Competitors

Oxford,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • OMass's estimated annual revenue is currently $16.3M per year.(i)
  • OMass's estimated revenue per employee is $155,000

Employee Data

  • OMass has 105 Employees.(i)
  • OMass grew their employee count by 5% last year.

OMass's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Office Manager and PA to the CEOReveal Email/Phone
4
SVP Finance and OperationsReveal Email/Phone
5
VP ImmunologyReveal Email/Phone
6
VP Medicinal ChemistryReveal Email/Phone
7
VP, PharmacologyReveal Email/Phone
8
VP, Platforms and FounderReveal Email/Phone
9
Associate Director - Finance & OperationsReveal Email/Phone
10
Founder & Director TechnologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is OMass?

OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of drug leads that not only bind to the target complex, but also exert a functional effect through modulating complex formation. These methods are being applied to drug discovery for a variety of complex targets, including membrane receptors, addressing severe unmet medical needs. OMass is backed by Syncona Ltd and Oxford Sciences Innovation.

keywords:N/A

N/A

Total Funding

105

Number of Employees

$16.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

OMass News

2022-04-17 - Syncona : OMass CEO Ros Deegan Named as a 2022 In Vivo Rising Leader

Oxford, United Kingdom - 19 April 2022 - OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines...

2022-04-06 - Publication in Nature by OMass Founder, Professor Dame ...

Publication in Nature by OMass Founder, Professor Dame Carol Robinson, Shows Power of Native Mass Spectrometry in Drug Discovery by...

2022-03-22 - OMass Establishes Scientific Advisory Board of Leading ...

Oxford, United Kingdom – 7 March 2022 – OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25.8M10514%N/A
#2
$7.5M1059%N/A
#3
$10.8M1067%N/A
#4
$18.2M10735%N/A
#5
$22.5M1075%N/A